| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.647 | 0.013 | 0.652 | Aldehyde oxidase inhibitor | 0.635 0.014 DBMET01297 0.642 0.014 DBMET00237 0.547 0.026 DBMET00238 0.26 0.079 DBMET00240 0.652 0.013 DBMET01298 0.652 0.013 DBMET01299 0.53 0.029 DBMET01296 | DBMET01299 | |
| 0.628 | 0.012 | 0.721 | 5 Hydroxytryptamine release stimulant | 0.548 0.02 DBMET01297 0.619 0.013 DBMET00237 0.721 0.006 DBMET00238 0.292 0.072 DBMET00240 0.569 0.018 DBMET01298 0.569 0.018 DBMET01299 0.658 0.01 DBMET01296 | DBMET00238 | |
| 0.629 | 0.022 | 0.792 | Analgesic | 0.597 0.027 DBMET01297 0.747 0.009 DBMET00237 0.589 0.029 DBMET00238 0.792 0.006 DBMET00240 0.448 0.066 DBMET01298 0.448 0.066 DBMET01299 0.55 0.037 DBMET01296 | DBMET00240 | |
| 0.614 | 0.019 | 0.723 | Antiobesity | 0.628 0.017 DBMET01297 0.656 0.014 DBMET00237 0.71 0.01 DBMET00238 0.715 0.01 DBMET00240 0.48 0.042 DBMET01298 0.48 0.042 DBMET01299 0.723 0.009 DBMET01296 | DBMET01296 | |
| 0.542 | 0.019 | 0.649 | Spasmolytic | 0.551 0.018 DBMET01297 0.649 0.009 DBMET00237 0.394 0.041 DBMET00238 0.603 0.013 DBMET00240 0.571 0.016 DBMET01298 0.571 0.016 DBMET01299 0.402 0.039 DBMET01296 | DBMET00237 | |
| 0.522 | 0.004 | 0.522 | Sigma receptor antagonist | 0.5 0.004 DBMET01297 0.073 0.022 DBMET00237 0.462 0.004 DBMET00238 0.239 0.008 DBMET00240 0.387 0.005 DBMET01298 0.387 0.005 DBMET01299 0.435 0.005 DBMET01296 | ||
| 0.501 | 0.009 | 0.501 | Sigma receptor agonist | 0.47 0.013 DBMET01297 0.463 0.013 DBMET00237 0.408 0.021 DBMET00238 0.372 0.026 DBMET00240 0.469 0.013 DBMET01298 0.469 0.013 DBMET01299 0.352 0.03 DBMET01296 | ||
| 0.509 | 0.023 | 0.509 | GABA C receptor rho-3 antagonist | 0.45 0.042 DBMET01297 0.406 0.059 DBMET00237 0.501 0.026 DBMET00238 0.362 0.079 DBMET00240 0.264 0.143 DBMET01298 0.264 0.143 DBMET01299 0.44 0.045 DBMET01296 | ||
| 0.491 | 0.012 | 0.506 | Psychostimulant | 0.48 0.013 DBMET01297 0.506 0.01 DBMET00237 0.479 0.013 DBMET00238 0.259 0.055 DBMET00240 0.454 0.015 DBMET01298 0.454 0.015 DBMET01299 0.468 0.014 DBMET01296 | DBMET00237 | |
| 0.441 | 0.005 | 0.474 | Tyrosine 3 hydroxylase inhibitor | 0.441 0.005 DBMET01297 0.354 0.015 DBMET00237 0.474 0.004 DBMET00238 0.335 0.02 DBMET00240 0.373 0.012 DBMET01298 0.373 0.012 DBMET01299 0.473 0.004 DBMET01296 | DBMET00238 | |
| 0.423 | 0.004 | 0.423 | Opioid kappa receptor antagonist | 0.408 0.004 DBMET01297 0.205 0.01 DBMET00237 0.4 0.004 DBMET00238 0.327 0.005 DBMET00240 0.359 0.004 DBMET01298 0.359 0.004 DBMET01299 0.386 0.004 DBMET01296 | ||
| 0.416 | 0.004 | 0.416 | Opioid antagonist | 0.355 0.005 DBMET01297 0.173 0.02 DBMET00237 0.381 0.005 DBMET00238 0.317 0.005 DBMET00240 0.249 0.008 DBMET01298 0.249 0.008 DBMET01299 0.323 0.005 DBMET01296 | ||
| 0.41 | 0.013 | 0.53 | 5 Hydroxytryptamine uptake stimulant | 0.456 0.007 DBMET01297 0.337 0.03 DBMET00237 0.489 0.005 DBMET00238 0.286 0.053 DBMET00240 0.444 0.008 DBMET01298 0.444 0.008 DBMET01299 0.53 0.004 DBMET01296 | DBMET01296 | |
| 0.4 | 0.004 | 0.4 | Opioid mu receptor antagonist | 0.342 0.004 DBMET01297 0.154 0.016 DBMET00237 0.369 0.004 DBMET00238 0.318 0.005 DBMET00240 0.23 0.006 DBMET01298 0.23 0.006 DBMET01299 0.308 0.005 DBMET01296 | ||
| 0.397 | 0.017 | 0.397 | Anesthetic general | 0.382 0.019 DBMET01297 0.384 0.019 DBMET00237 0.262 0.045 DBMET00238 0.159 0.104 DBMET00240 0.372 0.02 DBMET01298 0.372 0.02 DBMET01299 0.25 0.05 DBMET01296 | ||
| 0.438 | 0.089 | 0.539 | Caspase 9 stimulant | 0.455 0.08 DBMET01297 0.43 0.094 DBMET00237 0.462 0.077 DBMET00238 0.314 0.179 DBMET00240 0.539 0.047 DBMET01298 0.539 0.047 DBMET01299 0.478 0.069 DBMET01296 | DBMET01299 | |
| 0.35 | 0.004 | 0.35 | Dopamine uptake inhibitor | 0.317 0.004 DBMET01297 0.243 0.005 DBMET00237 0.269 0.005 DBMET00238 0.071 0.03 DBMET00240 0.248 0.005 DBMET01298 0.248 0.005 DBMET01299 0.243 0.005 DBMET01296 | ||
| 0.33 | 0.013 | 0.36 | Protein kinase stimulant | 0.344 0.012 DBMET01297 0.328 0.014 DBMET00237 0.318 0.015 DBMET00238 0.17 0.055 DBMET00240 0.36 0.011 DBMET01298 0.36 0.011 DBMET01299 0.332 0.013 DBMET01296 | DBMET01299 | |
| 0.388 | 0.082 | 0.413 | Histamine release inhibitor | 0.403 0.074 DBMET01297 0.413 0.069 DBMET00237 0.305 0.121 DBMET00238 0.358 0.096 DBMET01298 0.358 0.096 DBMET01299 0.327 0.11 DBMET01296 | DBMET00237 | |
| 0.31 | 0.005 | 0.31 | Opioid delta receptor antagonist | 0.274 0.005 DBMET01297 0.119 0.026 DBMET00237 0.308 0.005 DBMET00238 0.209 0.01 DBMET00240 0.211 0.01 DBMET01298 0.211 0.01 DBMET01299 0.271 0.005 DBMET01296 | ||
| 0.292 | 0.016 | 0.335 | Acetylcholine M1 receptor antagonist | 0.289 0.016 DBMET01297 0.335 0.01 DBMET00237 0.211 0.038 DBMET00238 0.251 0.025 DBMET00240 0.234 0.03 DBMET01298 0.234 0.03 DBMET01299 0.209 0.039 DBMET01296 | DBMET00237 | |
| 0.279 | 0.007 | 0.327 | 5 Hydroxytryptamine uptake inhibitor | 0.275 0.007 DBMET01297 0.1 0.026 DBMET00237 0.327 0.005 DBMET00238 0.094 0.028 DBMET00240 0.203 0.011 DBMET01298 0.203 0.011 DBMET01299 0.325 0.005 DBMET01296 | DBMET00238 | |
| 0.299 | 0.03 | 0.299 | 5 Hydroxytryptamine 1E antagonist | 0.296 0.032 DBMET01297 0.273 0.051 DBMET00237 0.235 0.091 DBMET00238 0.295 0.033 DBMET01298 0.295 0.033 DBMET01299 0.232 0.095 DBMET01296 | ||
| 0.286 | 0.022 | 0.293 | Neurotrophic factor enhancer | 0.293 0.02 DBMET01297 0.274 0.027 DBMET00237 0.26 0.033 DBMET00238 0.18 0.098 DBMET00240 0.277 0.025 DBMET01298 0.277 0.025 DBMET01299 0.266 0.03 DBMET01296 | DBMET01297 | |
| 0.314 | 0.051 | 0.34 | Cardiotonic | 0.34 0.042 DBMET01297 0.276 0.067 DBMET00238 0.239 0.09 DBMET00240 0.32 0.048 DBMET01298 0.32 0.048 DBMET01299 0.302 0.055 DBMET01296 | DBMET01297 | |
| 0.317 | 0.065 | 0.341 | Sodium/bile acid cotransporter inhibitor | 0.296 0.083 DBMET01297 0.341 0.045 DBMET00237 0.315 0.066 DBMET00238 0.253 0.124 DBMET00240 0.3 0.079 DBMET01298 0.3 0.079 DBMET01299 0.293 0.086 DBMET01296 | DBMET00237 | |
| 0.257 | 0.007 | 0.272 | Analgesic, opioid | 0.211 0.009 DBMET01297 0.127 0.02 DBMET00237 0.217 0.008 DBMET00238 0.272 0.006 DBMET00240 0.148 0.015 DBMET01298 0.148 0.015 DBMET01299 0.174 0.011 DBMET01296 | DBMET00240 | |
| 0.316 | 0.081 | 0.364 | Cholesterol antagonist | 0.322 0.078 DBMET01297 0.364 0.059 DBMET00237 0.268 0.113 DBMET00238 0.3 0.091 DBMET01298 0.3 0.091 DBMET01299 0.274 0.108 DBMET01296 | DBMET00237 | |
| 0.263 | 0.029 | 0.27 | Lipocortins synthesis antagonist | 0.27 0.028 DBMET01297 0.24 0.037 DBMET00237 0.251 0.033 DBMET00238 0.217 0.047 DBMET00240 0.239 0.037 DBMET01298 0.239 0.037 DBMET01299 0.258 0.031 DBMET01296 | DBMET01297 | |
| 0.278 | 0.059 | 0.478 | Superoxide dismutase inhibitor | 0.3 0.05 DBMET01297 0.194 0.124 DBMET00237 0.45 0.019 DBMET00238 0.202 0.115 DBMET00240 0.357 0.035 DBMET01298 0.357 0.035 DBMET01299 0.478 0.015 DBMET01296 | DBMET01296 | |
| 0.214 | 0.005 | 0.252 | Adrenaline uptake inhibitor | 0.213 0.005 DBMET01297 0.1 0.019 DBMET00237 0.251 0.005 DBMET00238 0.234 0.005 DBMET00240 0.161 0.008 DBMET01298 0.161 0.008 DBMET01299 0.252 0.005 DBMET01296 | DBMET01296 | |
| 0.215 | 0.007 | 0.215 | Prolactin inhibitor | 0.205 0.008 DBMET01297 0.19 0.01 DBMET00237 0.192 0.01 DBMET00238 0.114 0.043 DBMET00240 0.155 0.02 DBMET01298 0.155 0.02 DBMET01299 0.182 0.012 DBMET01296 | ||
| 0.23 | 0.025 | 0.278 | Cholinergic antagonist | 0.212 0.029 DBMET01297 0.253 0.02 DBMET00237 0.17 0.043 DBMET00238 0.278 0.017 DBMET00240 0.166 0.044 DBMET01298 0.166 0.044 DBMET01299 0.157 0.049 DBMET01296 | DBMET00240 | |
| 0.301 | 0.097 | 0.421 | Vasodilator, peripheral | 0.334 0.081 DBMET01297 0.421 0.049 DBMET00237 0.319 0.088 DBMET00238 0.375 0.064 DBMET01298 0.375 0.064 DBMET01299 0.351 0.073 DBMET01296 | DBMET00237 | |
| 0.215 | 0.021 | 0.26 | Acetylcholine muscarinic antagonist | 0.199 0.025 DBMET01297 0.26 0.013 DBMET00237 0.147 0.046 DBMET00238 0.197 0.025 DBMET00240 0.158 0.039 DBMET01298 0.158 0.039 DBMET01299 0.136 0.053 DBMET01296 | DBMET00237 | |
| 0.204 | 0.01 | 0.252 | Dopamine D1 antagonist | 0.223 0.009 DBMET01297 0.159 0.014 DBMET00237 0.096 0.026 DBMET00238 0.252 0.008 DBMET00240 0.242 0.008 DBMET01298 0.242 0.008 DBMET01299 0.103 0.024 DBMET01296 | DBMET00240 | |
| 0.203 | 0.01 | 0.205 | Creatine kinase inhibitor | 0.205 0.01 DBMET01297 0.187 0.013 DBMET00237 0.19 0.012 DBMET00238 0.156 0.021 DBMET00240 0.114 0.045 DBMET01298 0.114 0.045 DBMET01299 0.192 0.012 DBMET01296 | DBMET01297 | |
| 0.217 | 0.027 | 0.248 | Acetylcholine antagonist | 0.199 0.031 DBMET01297 0.248 0.021 DBMET00237 0.161 0.045 DBMET00238 0.192 0.033 DBMET00240 0.156 0.047 DBMET01298 0.156 0.047 DBMET01299 0.148 0.051 DBMET01296 | DBMET00237 | |
| 0.269 | 0.084 | 0.324 | Hypoxia-inducible factor 1 alpha inhibitor | 0.276 0.079 DBMET01297 0.229 0.12 DBMET00237 0.227 0.122 DBMET00238 0.324 0.055 DBMET01298 0.324 0.055 DBMET01299 0.234 0.115 DBMET01296 | DBMET01299 | |
| 0.232 | 0.051 | 0.239 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.232 0.051 DBMET01297 0.238 0.048 DBMET00237 0.182 0.09 DBMET00238 0.154 0.139 DBMET00240 0.239 0.048 DBMET01298 0.239 0.048 DBMET01299 0.182 0.09 DBMET01296 | DBMET01299 | |
| 0.2 | 0.019 | 0.2 | Nav1.1 sodium channel blocker | 0.175 0.025 DBMET01297 0.194 0.02 DBMET00237 0.146 0.035 DBMET00238 0.144 0.035 DBMET01298 0.144 0.035 DBMET01299 0.119 0.049 DBMET01296 | ||
| 0.205 | 0.031 | 0.314 | Anesthetic local | 0.211 0.029 DBMET01297 0.314 0.011 DBMET00237 0.105 0.078 DBMET00238 0.202 0.032 DBMET01298 0.202 0.032 DBMET01299 0.11 0.075 DBMET01296 | DBMET00237 | |
| 0.201 | 0.032 | 0.216 | Arachidonic acid antagonist | 0.211 0.024 DBMET01297 0.163 0.074 DBMET00237 0.206 0.027 DBMET00238 0.182 0.052 DBMET00240 0.195 0.038 DBMET01298 0.195 0.038 DBMET01299 0.216 0.02 DBMET01296 | DBMET01296 | |
| 0.174 | 0.013 | 0.187 | Dopamine D3 antagonist | 0.174 0.013 DBMET01297 0.089 0.028 DBMET00238 0.084 0.031 DBMET00240 0.187 0.012 DBMET01298 0.187 0.012 DBMET01299 0.089 0.029 DBMET01296 | DBMET01299 | |
| 0.31 | 0.153 | 0.368 | Cyclophilin D inhibitor | 0.344 0.126 DBMET01297 0.334 0.135 DBMET00238 0.256 0.206 DBMET01298 0.256 0.206 DBMET01299 0.368 0.11 DBMET01296 | DBMET01296 | |
| 0.2 | 0.049 | 0.2 | Antipruritic | 0.192 0.055 DBMET01297 0.194 0.053 DBMET00237 0.156 0.087 DBMET00238 0.176 0.068 DBMET00240 0.142 0.104 DBMET01298 0.142 0.104 DBMET01299 0.147 0.097 DBMET01296 | ||
| 0.167 | 0.016 | 0.169 | Ca2+-transporting ATPase inhibitor | 0.169 0.014 DBMET01297 0.166 0.017 DBMET00237 0.151 0.04 DBMET00238 0.142 0.067 DBMET00240 0.155 0.033 DBMET01298 0.155 0.033 DBMET01299 0.153 0.036 DBMET01296 | DBMET01297 | |
| 0.305 | 0.16 | 0.416 | 5 Hydroxytryptamine release inhibitor | 0.263 0.211 DBMET01297 0.32 0.143 DBMET00237 0.416 0.069 DBMET00238 0.245 0.235 DBMET01298 0.245 0.235 DBMET01299 0.37 0.099 DBMET01296 | DBMET00238 | |
| 0.186 | 0.044 | 0.214 | Neurotensin receptor agonist | 0.167 0.067 DBMET01297 0.16 0.079 DBMET00237 0.214 0.029 DBMET00238 0.149 0.104 DBMET00240 0.171 0.061 DBMET01298 0.171 0.061 DBMET01299 0.19 0.041 DBMET01296 | DBMET00238 | |
| 0.163 | 0.023 | 0.2 | Dopamine antagonist | 0.179 0.021 DBMET01297 0.08 0.048 DBMET00238 0.149 0.026 DBMET00240 0.2 0.019 DBMET01298 0.2 0.019 DBMET01299 0.088 0.043 DBMET01296 | DBMET01299 | |
| 0.167 | 0.028 | 0.266 | Butyrylcholinesterase inhibitor | 0.174 0.027 DBMET01297 0.133 0.041 DBMET00238 0.266 0.013 DBMET00240 0.182 0.025 DBMET01298 0.182 0.025 DBMET01299 0.138 0.039 DBMET01296 | DBMET00240 | |
| 0.177 | 0.044 | 0.229 | GABA C receptor rho-2 antagonist | 0.15 0.073 DBMET01297 0.144 0.081 DBMET00237 0.229 0.017 DBMET00238 0.126 0.114 DBMET00240 0.144 0.082 DBMET01298 0.144 0.082 DBMET01299 0.196 0.031 DBMET01296 | DBMET00238 | |
| 0.154 | 0.022 | 0.154 | Estrogen antagonist | 0.129 0.039 DBMET01297 0.134 0.033 DBMET00237 0.148 0.024 DBMET00238 0.129 0.039 DBMET00240 0.118 0.058 DBMET01298 0.118 0.058 DBMET01299 0.126 0.044 DBMET01296 | ||
| 0.15 | 0.02 | 0.15 | Acetylcholine nicotinic antagonist | 0.144 0.022 DBMET01297 0.106 0.036 DBMET00237 0.14 0.023 DBMET00238 0.095 0.043 DBMET00240 0.121 0.03 DBMET01298 0.121 0.03 DBMET01299 0.135 0.025 DBMET01296 | ||
| 0.292 | 0.164 | 0.473 | Calcium channel L-type activator | 0.473 0.039 DBMET00237 0.422 0.067 DBMET00238 0.24 0.217 DBMET00240 0.352 0.116 DBMET01296 | DBMET00237 | |
| 0.162 | 0.036 | 0.172 | 5 Hydroxytryptamine 2B antagonist | 0.152 0.04 DBMET01297 0.124 0.057 DBMET00238 0.127 0.054 DBMET00240 0.172 0.033 DBMET01298 0.172 0.033 DBMET01299 0.118 0.063 DBMET01296 | DBMET01299 | |
| 0.161 | 0.036 | 0.167 | Cystathionine beta-synthase inhibitor | 0.167 0.034 DBMET01297 0.12 0.058 DBMET00237 0.117 0.06 DBMET00238 0.09 0.089 DBMET00240 0.145 0.043 DBMET01298 0.145 0.043 DBMET01299 0.121 0.057 DBMET01296 | DBMET01297 | |
| 0.164 | 0.039 | 0.169 | Farnesoid X receptor antagonist | 0.158 0.044 DBMET01297 0.169 0.035 DBMET00238 0.125 0.092 DBMET00240 0.146 0.058 DBMET01298 0.146 0.058 DBMET01299 0.163 0.04 DBMET01296 | DBMET00238 | |
| 0.25 | 0.128 | 0.276 | Apoptosis antagonist | 0.272 0.106 DBMET01297 0.256 0.122 DBMET00237 0.238 0.14 DBMET00238 0.276 0.104 DBMET01298 0.276 0.104 DBMET01299 0.262 0.116 DBMET01296 | DBMET01299 | |
| 0.319 | 0.198 | 0.589 | Antiinflammatory | 0.379 0.153 DBMET01297 0.589 0.056 DBMET00237 0.302 0.214 DBMET00238 0.333 0.186 DBMET01298 0.333 0.186 DBMET01299 0.362 0.164 DBMET01296 | DBMET00237 | |
| 0.129 | 0.009 | 0.129 | Opioid mu receptor agonist | 0.1 0.013 DBMET01297 0.054 0.026 DBMET00237 0.115 0.01 DBMET00238 0.101 0.013 DBMET00240 0.065 0.021 DBMET01298 0.065 0.021 DBMET01299 0.087 0.016 DBMET01296 | ||
| 0.128 | 0.011 | 0.152 | Neuropeptide Y5 antagonist | 0.118 0.013 DBMET01297 0.152 0.008 DBMET00238 0.052 0.035 DBMET00240 0.066 0.027 DBMET01298 0.066 0.027 DBMET01299 0.142 0.009 DBMET01296 | DBMET00238 | |
| 0.14 | 0.024 | 0.186 | Alpha 1b adrenoreceptor antagonist | 0.135 0.025 DBMET01297 0.081 0.045 DBMET00237 0.087 0.041 DBMET00238 0.139 0.024 DBMET00240 0.186 0.016 DBMET01298 0.186 0.016 DBMET01299 0.084 0.043 DBMET01296 | DBMET01299 | |
| 0.123 | 0.008 | 0.128 | Dopamine transporter inhibitor | 0.123 0.008 DBMET01297 0.128 0.008 DBMET00237 0.117 0.009 DBMET00238 0.059 0.025 DBMET00240 0.103 0.011 DBMET01298 0.103 0.011 DBMET01299 0.117 0.009 DBMET01296 | DBMET00237 | |
| 0.134 | 0.021 | 0.134 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET01297 0.122 0.03 DBMET00237 0.131 0.023 DBMET00238 0.11 0.047 DBMET00240 0.103 0.058 DBMET01298 0.103 0.058 DBMET01299 0.112 0.044 DBMET01296 | ||
| 0.146 | 0.037 | 0.173 | Antiadrenergic | 0.163 0.032 DBMET01297 0.127 0.043 DBMET00237 0.139 0.039 DBMET00238 0.154 0.035 DBMET00240 0.173 0.03 DBMET01298 0.173 0.03 DBMET01299 0.155 0.034 DBMET01296 | DBMET01299 | |
| 0.178 | 0.07 | 0.232 | Succinate dehydrogenase inhibitor | 0.2 0.048 DBMET01297 0.149 0.114 DBMET00237 0.207 0.044 DBMET00238 0.163 0.09 DBMET00240 0.199 0.05 DBMET01298 0.199 0.05 DBMET01299 0.232 0.029 DBMET01296 | DBMET01296 | |
| 0.118 | 0.01 | 0.118 | Opioid agonist | 0.088 0.016 DBMET01297 0.052 0.038 DBMET00237 0.118 0.01 DBMET00238 0.118 0.01 DBMET00240 0.063 0.027 DBMET01298 0.063 0.027 DBMET01299 0.087 0.016 DBMET01296 | ||
| 0.225 | 0.118 | 0.279 | Lipoxygenase inhibitor | 0.247 0.102 DBMET01297 0.225 0.118 DBMET00238 0.279 0.082 DBMET01298 0.279 0.082 DBMET01299 0.248 0.102 DBMET01296 | DBMET01299 | |
| 0.122 | 0.016 | 0.145 | Acetylcholine M2 receptor antagonist | 0.094 0.023 DBMET01297 0.145 0.012 DBMET00237 0.07 0.037 DBMET00238 0.085 0.027 DBMET00240 0.072 0.035 DBMET01298 0.072 0.035 DBMET01299 0.055 0.05 DBMET01296 | DBMET00237 | |
| 0.222 | 0.116 | 0.222 | Gastrin inhibitor | 0.21 0.134 DBMET01297 | ||
| 0.141 | 0.037 | 0.169 | Adrenaline antagonist | 0.158 0.033 DBMET01297 0.123 0.043 DBMET00237 0.135 0.039 DBMET00238 0.149 0.035 DBMET00240 0.169 0.03 DBMET01298 0.169 0.03 DBMET01299 0.151 0.034 DBMET01296 | DBMET01299 | |
| 0.116 | 0.012 | 0.116 | Estrogen-related receptor beta agonist | 0.103 0.021 DBMET01297 0.106 0.018 DBMET00237 0.106 0.018 DBMET00238 0.092 0.037 DBMET00240 0.098 0.027 DBMET01298 0.098 0.027 DBMET01299 0.094 0.032 DBMET01296 | ||
| 0.145 | 0.041 | 0.188 | Alpha 2b adrenoreceptor antagonist | 0.151 0.038 DBMET01297 0.168 0.032 DBMET00237 0.125 0.054 DBMET00238 0.188 0.027 DBMET01298 0.188 0.027 DBMET01299 0.13 0.051 DBMET01296 | DBMET01299 | |
| 0.131 | 0.03 | 0.145 | Anabolic | 0.127 0.033 DBMET01297 0.145 0.021 DBMET00237 0.13 0.031 DBMET00238 0.109 0.051 DBMET00240 0.094 0.072 DBMET01298 0.094 0.072 DBMET01299 0.126 0.034 DBMET01296 | DBMET00237 | |
| 0.148 | 0.049 | 0.155 | Aldehyde dehydrogenase inhibitor | 0.11 0.082 DBMET01297 0.105 0.089 DBMET00237 0.155 0.045 DBMET00238 0.1 0.097 DBMET00240 0.115 0.076 DBMET01296 | DBMET00238 | |
| 0.128 | 0.037 | 0.13 | Acetylcholine release stimulant | 0.121 0.047 DBMET01297 0.115 0.057 DBMET00237 0.13 0.034 DBMET01298 0.13 0.034 DBMET01299 | DBMET01299 | |
| 0.195 | 0.107 | 0.214 | RNA-directed DNA polymerase inhibitor | 0.214 0.08 DBMET01297 0.193 0.111 DBMET00238 0.198 0.103 DBMET01298 0.198 0.103 DBMET01299 0.212 0.083 DBMET01296 | DBMET01297 | |
| 0.23 | 0.143 | 0.306 | Interleukin 2 agonist | 0.214 0.166 DBMET01297 0.306 0.069 DBMET00237 0.238 0.133 DBMET00238 0.222 0.154 DBMET01296 | DBMET00237 | |
| 0.102 | 0.018 | 0.183 | Acetylcholine M3 receptor antagonist | 0.082 0.025 DBMET01297 0.183 0.008 DBMET00237 0.074 0.029 DBMET00238 0.085 0.024 DBMET00240 0.06 0.042 DBMET01298 0.06 0.042 DBMET01299 0.06 0.041 DBMET01296 | DBMET00237 | |
| 0.129 | 0.046 | 0.131 | Transcription factor STAT6 inhibitor | 0.122 0.056 DBMET01297 0.131 0.042 DBMET00237 0.116 0.067 DBMET00238 0.11 0.081 DBMET01296 | DBMET00237 | |
| 0.15 | 0.068 | 0.2 | Lipid peroxidase inhibitor | 0.18 0.051 DBMET01297 0.121 0.093 DBMET00237 0.168 0.056 DBMET00238 0.179 0.051 DBMET01298 0.179 0.051 DBMET01299 0.2 0.042 DBMET01296 | DBMET01296 | |
| 0.101 | 0.022 | 0.101 | 5 Hydroxytryptamine 1D antagonist | 0.093 0.025 DBMET01297 0.061 0.048 DBMET00238 0.092 0.025 DBMET01298 0.092 0.025 DBMET01299 0.056 0.053 DBMET01296 | ||
| 0.153 | 0.074 | 0.345 | Cholinergic | 0.159 0.069 DBMET01297 0.117 0.112 DBMET00238 0.345 0.014 DBMET00240 0.18 0.056 DBMET01298 0.18 0.056 DBMET01299 0.121 0.106 DBMET01296 | DBMET00240 | |
| 0.128 | 0.049 | 0.128 | 5 Hydroxytryptamine 3A agonist | 0.098 0.078 DBMET01297 0.096 0.08 DBMET00238 | ||
| 0.169 | 0.091 | 0.218 | P-glycoprotein inhibitor | 0.173 0.086 DBMET01297 0.139 0.134 DBMET00238 0.218 0.054 DBMET01298 0.218 0.054 DBMET01299 0.142 0.129 DBMET01296 | DBMET01299 | |
| 0.102 | 0.026 | 0.102 | Estrogen receptor alpha antagonist | 0.095 0.031 DBMET01297 0.084 0.043 DBMET00237 0.093 0.032 DBMET00238 0.077 0.053 DBMET01298 0.077 0.053 DBMET01299 0.087 0.038 DBMET01296 | ||
| 0.112 | 0.036 | 0.112 | Histamine N-methyltransferase inhibitor | 0.092 0.054 DBMET01297 0.092 0.054 DBMET00238 | ||
| 0.1 | 0.024 | 0.1 | Neuronal nicotinic receptor antagonist | 0.095 0.026 DBMET01297 0.063 0.051 DBMET00237 0.094 0.027 DBMET00238 0.063 0.051 DBMET00240 0.077 0.039 DBMET01298 0.077 0.039 DBMET01299 0.09 0.029 DBMET01296 | ||
| 0.12 | 0.045 | 0.151 | DOPA decarboxylase inhibitor | 0.129 0.036 DBMET01297 0.096 0.083 DBMET00237 0.14 0.027 DBMET00238 0.11 0.058 DBMET00240 0.1 0.075 DBMET01298 0.1 0.075 DBMET01299 0.151 0.021 DBMET01296 | DBMET01296 | |
| 0.108 | 0.034 | 0.109 | Bile acid receptor antagonist | 0.107 0.036 DBMET01297 0.092 0.068 DBMET00237 0.109 0.032 DBMET00238 0.098 0.054 DBMET01298 0.098 0.054 DBMET01299 0.108 0.034 DBMET01296 | DBMET00238 | |
| 0.136 | 0.063 | 0.212 | Toll-Like receptor 2 antagonist | 0.145 0.056 DBMET01297 0.113 0.085 DBMET00237 0.205 0.021 DBMET00238 0.172 0.039 DBMET01298 0.172 0.039 DBMET01299 0.212 0.019 DBMET01296 | DBMET01296 | |
| 0.197 | 0.124 | 0.21 | Neuropeptide Y2 antagonist | 0.182 0.155 DBMET00237 0.21 0.102 DBMET00238 0.18 0.16 DBMET01296 | DBMET00238 | |
| 0.122 | 0.048 | 0.15 | Alpha 2c adrenoreceptor antagonist | 0.124 0.047 DBMET01297 0.144 0.035 DBMET00237 0.088 0.077 DBMET00238 0.15 0.032 DBMET01298 0.15 0.032 DBMET01299 0.09 0.075 DBMET01296 | DBMET01299 | |
| 0.097 | 0.026 | 0.097 | CC chemokine 5 receptor agonist | 0.084 0.051 DBMET01297 0.082 0.057 DBMET00237 0.091 0.035 DBMET00238 0.08 0.066 DBMET01296 | ||
| 0.118 | 0.048 | 0.202 | Alpha adrenoreceptor antagonist | 0.129 0.044 DBMET01297 0.084 0.068 DBMET00237 0.089 0.064 DBMET00238 0.127 0.045 DBMET00240 0.202 0.027 DBMET01298 0.202 0.027 DBMET01299 0.096 0.059 DBMET01296 | DBMET01299 | |
| 0.138 | 0.069 | 0.144 | Nav1.6 sodium channel blocker | 0.123 0.092 DBMET01297 0.144 0.062 DBMET00237 | DBMET00237 | |
| 0.11 | 0.041 | 0.178 | NMDA receptor antagonist | 0.081 0.064 DBMET01297 0.118 0.037 DBMET00237 0.178 0.018 DBMET00238 0.133 0.03 DBMET01296 | DBMET00238 | |
| 0.129 | 0.061 | 0.132 | Papain-like protease (SARS coronavirus) inhibitor | 0.125 0.07 DBMET01297 0.116 0.092 DBMET00237 0.132 0.057 DBMET00238 0.124 0.073 DBMET01298 0.124 0.073 DBMET01299 0.127 0.066 DBMET01296 | DBMET00238 | |
| 0.232 | 0.164 | 0.242 | Immunosuppressant | 0.242 0.154 DBMET01297 0.227 0.169 DBMET00238 0.231 0.165 DBMET01298 0.231 0.165 DBMET01299 0.238 0.158 DBMET01296 | DBMET01297 | |
| 0.075 | 0.008 | 0.257 | Substance P antagonist | 0.072 0.009 DBMET01297 0.257 0.004 DBMET00237 0.092 0.006 DBMET00238 0.147 0.005 DBMET00240 0.06 0.012 DBMET01298 0.06 0.012 DBMET01299 0.089 0.006 DBMET01296 | DBMET00237 | |
| 0.081 | 0.016 | 0.166 | Neurokinin antagonist | 0.075 0.018 DBMET01297 0.166 0.005 DBMET00237 0.095 0.013 DBMET00238 0.103 0.01 DBMET00240 0.055 0.028 DBMET01298 0.055 0.028 DBMET01299 0.09 0.014 DBMET01296 | DBMET00237 | |
| 0.133 | 0.068 | 0.144 | Sphingosine 1-phosphate receptor 2 antagonist | 0.144 0.049 DBMET01297 0.12 0.096 DBMET00237 0.125 0.085 DBMET00238 0.125 0.085 DBMET01298 0.125 0.085 DBMET01299 0.136 0.062 DBMET01296 | DBMET01297 | |
| 0.118 | 0.054 | 0.254 | GABA C receptor antagonist | 0.107 0.068 DBMET01297 0.103 0.073 DBMET00237 0.254 0.006 DBMET00238 0.231 0.008 DBMET01296 | DBMET00238 | |
| 0.148 | 0.084 | 0.183 | Melanin inhibitor | 0.151 0.08 DBMET01297 0.16 0.069 DBMET00237 0.179 0.052 DBMET00238 0.165 0.064 DBMET01298 0.165 0.064 DBMET01299 0.183 0.05 DBMET01296 | DBMET01296 | |
| 0.082 | 0.02 | 0.09 | Acetyl-CoA transferase inhibitor | 0.081 0.02 DBMET01297 0.09 0.017 DBMET00238 0.062 0.029 DBMET01298 0.062 0.029 DBMET01299 0.09 0.017 DBMET01296 | DBMET01296 | |
| 0.088 | 0.027 | 0.12 | Alpha 1d adrenoreceptor antagonist | 0.077 0.032 DBMET01297 0.05 0.049 DBMET00237 0.061 0.04 DBMET00238 0.12 0.019 DBMET01298 0.12 0.019 DBMET01299 0.052 0.047 DBMET01296 | DBMET01299 | |
| 0.07 | 0.008 | 0.195 | Dopamine D5 agonist | 0.072 0.008 DBMET01297 0.053 0.015 DBMET00237 0.19 0.002 DBMET00238 0.052 0.016 DBMET00240 0.045 0.022 DBMET01298 0.045 0.022 DBMET01299 0.195 0.002 DBMET01296 | DBMET01296 | |
| 0.145 | 0.085 | 0.16 | Interferon gamma antagonist | 0.149 0.079 DBMET01297 0.146 0.084 DBMET00237 0.156 0.07 DBMET00238 0.142 0.089 DBMET01298 0.142 0.089 DBMET01299 0.16 0.066 DBMET01296 | DBMET01296 | |
| 0.072 | 0.014 | 0.13 | Dopamine D5 antagonist | 0.085 0.011 DBMET01297 0.073 0.014 DBMET00237 0.13 0.007 DBMET00240 0.074 0.014 DBMET01298 0.074 0.014 DBMET01299 0.042 0.031 DBMET01296 | DBMET00240 | |
| 0.128 | 0.071 | 0.278 | Acetylcholinesterase inhibitor | 0.133 0.067 DBMET01297 0.278 0.016 DBMET00240 0.164 0.047 DBMET01298 0.164 0.047 DBMET01299 | DBMET00240 | |
| 0.132 | 0.075 | 0.163 | Toll-Like receptor 9 antagonist | 0.127 0.08 DBMET01297 0.163 0.055 DBMET01298 0.163 0.055 DBMET01299 | DBMET01299 | |
| 0.174 | 0.118 | 0.228 | Cyclic AMP phosphodiesterase inhibitor | 0.194 0.098 DBMET01297 0.224 0.078 DBMET00237 0.228 0.075 DBMET01298 0.228 0.075 DBMET01299 0.162 0.132 DBMET01296 | DBMET01299 | |
| 0.139 | 0.084 | 0.207 | Adenylate cyclase stimulant | 0.151 0.061 DBMET01297 0.165 0.041 DBMET00237 0.193 0.017 DBMET00238 0.134 0.093 DBMET01298 0.134 0.093 DBMET01299 0.207 0.011 DBMET01296 | DBMET01296 | |
| 0.138 | 0.083 | 0.14 | Heat shock protein 70 antagonist | 0.14 0.074 DBMET01297 0.131 0.115 DBMET00237 0.14 0.076 DBMET01298 0.14 0.076 DBMET01299 | DBMET01299 | |
| 0.171 | 0.117 | 0.175 | Hypolipemic | 0.169 0.119 DBMET01297 0.175 0.114 DBMET00238 0.173 0.116 DBMET01296 | DBMET00238 | |
| 0.218 | 0.165 | 0.285 | Vasodilator, coronary | 0.236 0.148 DBMET01297 0.261 0.123 DBMET00237 0.215 0.169 DBMET00238 0.285 0.1 DBMET01298 0.285 0.1 DBMET01299 0.233 0.151 DBMET01296 | DBMET01299 | |
| 0.101 | 0.05 | 0.112 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET01297 0.112 0.033 DBMET00237 0.087 0.083 DBMET00238 0.094 0.064 DBMET01298 0.094 0.064 DBMET01299 0.091 0.071 DBMET01296 | DBMET00237 | |
| 0.071 | 0.021 | 0.071 | Nicotinic receptor alpha7 subunit antagonist | 0.066 0.024 DBMET01297 0.049 0.046 DBMET00237 0.06 0.029 DBMET00238 0.052 0.039 DBMET01298 0.052 0.039 DBMET01299 0.056 0.033 DBMET01296 | ||
| 0.1 | 0.05 | 0.109 | Protein kinase C zeta inhibitor | 0.097 0.055 DBMET01297 0.109 0.041 DBMET00238 0.092 0.062 DBMET01298 0.092 0.062 DBMET01299 0.105 0.045 DBMET01296 | DBMET00238 | |
| 0.231 | 0.181 | 0.278 | 15-Lipoxygenase inhibitor | 0.256 0.16 DBMET01297 0.278 0.144 DBMET01298 0.278 0.144 DBMET01299 0.21 0.203 DBMET01296 | DBMET01299 | |
| 0.138 | 0.087 | 0.146 | Diuretic | 0.146 0.081 DBMET01297 0.117 0.108 DBMET01296 | DBMET01297 | |
| 0.125 | 0.076 | 0.157 | Vanilloid 1 agonist | 0.135 0.057 DBMET01297 0.136 0.057 DBMET00238 0.157 0.032 DBMET01298 0.157 0.032 DBMET01299 0.147 0.042 DBMET01296 | DBMET01299 | |
| 0.104 | 0.056 | 0.203 | GABA C receptor rho-1 antagonist | 0.09 0.079 DBMET01297 0.09 0.078 DBMET00237 0.203 0.008 DBMET00238 0.178 0.012 DBMET01296 | DBMET00238 | |
| 0.056 | 0.008 | 0.056 | Delayed rectifier potassium channel blocker | 0.052 0.01 DBMET01297 0.038 0.024 DBMET00237 | ||
| 0.067 | 0.02 | 0.067 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.067 0.02 DBMET01297 0.047 0.033 DBMET00238 0.041 0.039 DBMET01298 0.041 0.039 DBMET01299 0.047 0.033 DBMET01296 | ||
| 0.155 | 0.109 | 0.195 | Non-steroidal antiinflammatory agent | 0.166 0.098 DBMET01297 0.149 0.116 DBMET00238 0.195 0.075 DBMET01298 0.195 0.075 DBMET01299 0.158 0.105 DBMET01296 | DBMET01299 | |
| 0.148 | 0.103 | 0.24 | Tumour necrosis factor antagonist | 0.156 0.094 DBMET01297 0.189 0.06 DBMET00238 0.24 0.034 DBMET01298 0.24 0.034 DBMET01299 0.198 0.054 DBMET01296 | DBMET01299 | |
| 0.054 | 0.009 | 0.054 | Sigma 2 receptor antagonist | 0.037 0.014 DBMET01297 0.033 0.015 DBMET00237 0.024 0.021 DBMET00238 0.043 0.012 DBMET01298 0.043 0.012 DBMET01299 | ||
| 0.089 | 0.044 | 0.096 | Glycine receptor antagonist | 0.089 0.044 DBMET01297 0.074 0.067 DBMET00237 0.096 0.036 DBMET00238 0.096 0.036 DBMET01296 | DBMET01296 | |
| 0.068 | 0.026 | 0.068 | Prolactin release inhibitor | 0.068 0.026 DBMET01297 0.065 0.034 DBMET00237 0.06 0.051 DBMET00238 0.062 0.043 DBMET01298 0.062 0.043 DBMET01299 0.06 0.051 DBMET01296 | ||
| 0.071 | 0.03 | 0.129 | Acetylcholine M5 receptor antagonist | 0.069 0.032 DBMET01297 0.129 0.011 DBMET00237 0.062 0.039 DBMET00240 | DBMET00237 | |
| 0.066 | 0.026 | 0.069 | Lipocortins synthesis agonist | 0.068 0.023 DBMET01297 0.056 0.045 DBMET00237 0.067 0.025 DBMET00238 0.062 0.033 DBMET00240 0.063 0.03 DBMET01298 0.063 0.03 DBMET01299 0.069 0.023 DBMET01296 | DBMET01296 | |
| 0.147 | 0.107 | 0.249 | DNA methyltransferase I inhibitor | 0.167 0.088 DBMET01297 0.249 0.048 DBMET01298 0.249 0.048 DBMET01299 | DBMET01299 | |
| 0.088 | 0.048 | 0.154 | Alpha 1 adrenoreceptor antagonist | 0.089 0.048 DBMET01297 0.126 0.035 DBMET00240 0.154 0.028 DBMET01298 0.154 0.028 DBMET01299 | DBMET01299 | |
| 0.049 | 0.01 | 0.049 | Sigma 1 receptor antagonist | 0.04 0.013 DBMET01297 0.027 0.018 DBMET00237 0.028 0.018 DBMET00238 0.035 0.015 DBMET01298 0.035 0.015 DBMET01299 | ||
| 0.065 | 0.026 | 0.078 | Ryanodine receptor antagonist | 0.066 0.023 DBMET01297 0.059 0.039 DBMET00237 0.071 0.016 DBMET00238 0.078 0.01 DBMET01298 0.078 0.01 DBMET01299 0.073 0.014 DBMET01296 | DBMET01299 | |
| 0.129 | 0.092 | 0.298 | Peroxidase inhibitor | 0.133 0.088 DBMET01297 0.258 0.046 DBMET00237 0.289 0.039 DBMET00238 0.298 0.038 DBMET01296 | DBMET01296 | |
| 0.054 | 0.017 | 0.161 | Neurokinin 1 antagonist | 0.051 0.019 DBMET01297 0.161 0.005 DBMET00237 0.064 0.013 DBMET00238 0.085 0.009 DBMET00240 0.042 0.027 DBMET01298 0.042 0.027 DBMET01299 0.06 0.014 DBMET01296 | DBMET00237 | |
| 0.131 | 0.096 | 0.15 | Pregnane X receptor agonist | 0.131 0.096 DBMET01297 0.15 0.054 DBMET00237 | DBMET00237 | |
| 0.06 | 0.025 | 0.06 | Glycine transporter 2 inhibitor | 0.04 0.038 DBMET00237 | ||
| 0.042 | 0.008 | 0.042 | Liver X receptor alpha antagonist | 0.042 0.008 DBMET01297 0.04 0.009 DBMET00238 0.033 0.015 DBMET00240 0.037 0.011 DBMET01298 0.037 0.011 DBMET01299 0.04 0.009 DBMET01296 | ||
| 0.06 | 0.026 | 0.064 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.027 DBMET01297 0.064 0.022 DBMET00238 0.06 0.026 DBMET00240 0.063 0.023 DBMET01296 | DBMET00238 | |
| 0.131 | 0.098 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.143 0.073 DBMET01297 0.137 0.085 DBMET00238 0.149 0.064 DBMET01296 | DBMET01296 | |
| 0.039 | 0.005 | 0.039 | Estrogen-related receptor gamma antagonist | 0.033 0.011 DBMET01297 0.037 0.007 DBMET00237 0.03 0.016 DBMET00238 | ||
| 0.042 | 0.009 | 0.042 | Estrogen-related receptor beta antagonist | 0.033 0.021 DBMET01297 0.041 0.01 DBMET00237 0.039 0.011 DBMET00238 0.032 0.024 DBMET00240 0.03 0.028 DBMET01296 | ||
| 0.082 | 0.05 | 0.082 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.073 0.057 DBMET01297 0.08 0.051 DBMET01298 0.08 0.051 DBMET01299 | ||
| 0.044 | 0.012 | 0.056 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 DBMET01297 0.056 0.005 DBMET00237 | DBMET00237 | |
| 0.118 | 0.087 | 0.154 | Toll-Like receptor antagonist | 0.135 0.067 DBMET01297 0.154 0.053 DBMET01298 0.154 0.053 DBMET01299 0.114 0.094 DBMET01296 | DBMET01299 | |
| 0.138 | 0.108 | 0.174 | Nitric oxide antagonist | 0.154 0.092 DBMET01297 0.148 0.097 DBMET00237 0.141 0.104 DBMET00238 0.174 0.08 DBMET01298 0.174 0.08 DBMET01299 0.159 0.088 DBMET01296 | DBMET01299 | |
| 0.117 | 0.087 | 0.133 | Nav1.2 sodium channel blocker | 0.133 0.07 DBMET00237 | DBMET00237 | |
| 0.075 | 0.045 | 0.096 | Glycine receptor agonist | 0.077 0.043 DBMET01297 0.094 0.025 DBMET00238 0.067 0.061 DBMET01298 0.067 0.061 DBMET01299 0.096 0.023 DBMET01296 | DBMET01296 | |
| 0.1 | 0.071 | 0.107 | Falcipain 3 inhibitor | 0.107 0.063 DBMET01297 0.097 0.073 DBMET01298 0.097 0.073 DBMET01299 | DBMET01297 | |
| 0.054 | 0.026 | 0.061 | Melanocortin antagonist | 0.053 0.027 DBMET01297 0.061 0.02 DBMET00238 0.043 0.039 DBMET01298 0.043 0.039 DBMET01299 0.06 0.021 DBMET01296 | DBMET00238 | |
| 0.044 | 0.017 | 0.049 | Opioid delta receptor agonist | 0.035 0.025 DBMET01297 0.049 0.014 DBMET00238 0.038 0.021 DBMET01296 | DBMET00238 | |
| 0.075 | 0.049 | 0.084 | Glutamate decarboxylase inhibitor | 0.081 0.043 DBMET01297 0.084 0.041 DBMET00237 0.073 0.052 DBMET00238 0.079 0.045 DBMET01296 | DBMET00237 | |
| 0.105 | 0.079 | 0.114 | Photosensitizer | 0.114 0.066 DBMET00237 0.106 0.077 DBMET00238 | DBMET00237 | |
| 0.05 | 0.024 | 0.065 | Opioid kappa receptor agonist | 0.04 0.033 DBMET01297 0.049 0.024 DBMET00237 0.065 0.016 DBMET00240 | DBMET00240 | |
| 0.039 | 0.014 | 0.039 | Liver X receptor antagonist | 0.039 0.014 DBMET01297 0.038 0.015 DBMET00238 0.028 0.026 DBMET00240 0.033 0.019 DBMET01298 0.033 0.019 DBMET01299 0.037 0.016 DBMET01296 | ||
| 0.069 | 0.044 | 0.069 | Glutamate (mGluR7) antagonist | 0.065 0.053 DBMET00237 | ||
| 0.029 | 0.005 | 0.033 | NMDA receptor phencyclidine site antagonist | 0.019 0.008 DBMET01297 0.025 0.005 DBMET00237 0.033 0.004 DBMET00238 0.015 0.011 DBMET01298 0.015 0.011 DBMET01299 0.022 0.006 DBMET01296 | DBMET00238 | |
| 0.089 | 0.065 | 0.1 | Glutamate release inhibitor | 0.088 0.067 DBMET01297 0.1 0.043 DBMET00237 0.083 0.08 DBMET01298 0.083 0.08 DBMET01299 | DBMET00237 | |
| 0.08 | 0.057 | 0.107 | Histamine H1 receptor antagonist | 0.077 0.06 DBMET01297 0.107 0.037 DBMET00240 | DBMET00240 | |
| 0.106 | 0.083 | 0.13 | Interleukin 8 antagonist | 0.107 0.082 DBMET01297 0.129 0.051 DBMET00238 0.13 0.05 DBMET01296 | DBMET01296 | |
| 0.072 | 0.05 | 0.109 | Alpha 1a adrenoreceptor antagonist | 0.069 0.051 DBMET01297 0.109 0.033 DBMET01298 0.109 0.033 DBMET01299 | DBMET01299 | |
| 0.092 | 0.07 | 0.118 | Sphingomyelinase inhibitor | 0.09 0.072 DBMET01297 0.118 0.043 DBMET00237 0.108 0.051 DBMET01298 0.108 0.051 DBMET01299 | DBMET00237 | |
| 0.045 | 0.025 | 0.052 | Nerve growth factor antagonist | 0.052 0.016 DBMET01297 | DBMET01297 | |
| 0.062 | 0.042 | 0.091 | NMDA 2C receptor antagonist | 0.082 0.024 DBMET00237 0.091 0.019 DBMET00238 0.069 0.034 DBMET01296 | DBMET00238 | |
| 0.058 | 0.038 | 0.064 | Fatty acid synthase inhibitor | 0.064 0.031 DBMET01297 | DBMET01297 | |
| 0.053 | 0.034 | 0.173 | Estrogen agonist | 0.173 0.01 DBMET00237 0.048 0.037 DBMET00238 | DBMET00237 | |
| 0.026 | 0.008 | 0.026 | Progesterone agonist | 0.026 0.008 DBMET01297 0.026 0.008 DBMET00238 0.018 0.012 DBMET00240 0.018 0.012 DBMET01298 0.018 0.012 DBMET01299 0.026 0.008 DBMET01296 | ||
| 0.102 | 0.084 | 0.135 | DNA polymerase I inhibitor | 0.132 0.06 DBMET01297 0.115 0.072 DBMET00237 0.104 0.082 DBMET00238 0.122 0.067 DBMET01298 0.122 0.067 DBMET01299 0.135 0.058 DBMET01296 | DBMET01296 | |
| 0.156 | 0.139 | 0.247 | Free radical scavenger | 0.211 0.089 DBMET01297 0.158 0.136 DBMET00237 0.17 0.124 DBMET00238 0.247 0.07 DBMET01298 0.247 0.07 DBMET01299 0.227 0.079 DBMET01296 | DBMET01299 | |
| 0.101 | 0.087 | 0.138 | Cholesterol synthesis inhibitor | 0.107 0.079 DBMET01297 0.138 0.051 DBMET00237 0.097 0.091 DBMET00238 0.114 0.071 DBMET01298 0.114 0.071 DBMET01299 0.104 0.082 DBMET01296 | DBMET00237 | |
| 0.155 | 0.141 | 0.246 | Antiamyloidogenic | 0.18 0.114 DBMET01297 0.246 0.073 DBMET01298 0.246 0.073 DBMET01299 0.161 0.133 DBMET01296 | DBMET01299 | |
| 0.031 | 0.018 | 0.031 | Liver X receptor beta antagonist | 0.027 0.022 DBMET00238 | ||
| 0.104 | 0.092 | 0.118 | Nav1.3 sodium channel blocker | 0.118 0.076 DBMET00237 | DBMET00237 | |
| 0.075 | 0.063 | 0.094 | MAP kinase kinase 7 inhibitor | 0.094 0.019 DBMET00238 0.086 0.031 DBMET01296 | DBMET00238 | |
| 0.086 | 0.075 | 0.123 | 5-Lipoxygenase inhibitor | 0.109 0.057 DBMET01297 0.099 0.065 DBMET00238 0.11 0.056 DBMET01298 0.11 0.056 DBMET01299 0.123 0.049 DBMET01296 | DBMET01296 | |
| 0.057 | 0.046 | 0.113 | Androgen agonist | 0.113 0.011 DBMET00237 0.06 0.041 DBMET00238 0.056 0.047 DBMET01296 | DBMET00237 | |
| 0.034 | 0.024 | 0.037 | Estrogen receptor alpha agonist | 0.037 0.022 DBMET00237 0.036 0.023 DBMET00238 | DBMET00237 | |
| 0.083 | 0.072 | 0.117 | Protein kinase C delta inhibitor | 0.105 0.048 DBMET00238 0.117 0.039 DBMET00240 0.097 0.055 DBMET01296 | DBMET00240 | |
| 0.069 | 0.059 | 0.069 | Acetylcholine M4 receptor antagonist | 0.065 0.064 DBMET01297 0.065 0.063 DBMET00240 | ||
| 0.052 | 0.043 | 0.083 | Phosphodiesterase 4C inhibitor | 0.052 0.042 DBMET00238 0.083 0.02 DBMET01298 0.083 0.02 DBMET01299 | DBMET01299 | |
| 0.051 | 0.042 | 0.059 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.03 DBMET00238 | DBMET00238 | |
| 0.068 | 0.06 | 0.103 | Alpha 2a adrenoreceptor antagonist | 0.082 0.047 DBMET01297 0.086 0.044 DBMET00237 0.066 0.062 DBMET00238 0.103 0.035 DBMET01298 0.103 0.035 DBMET01299 0.079 0.049 DBMET01296 | DBMET01299 | |
| 0.038 | 0.029 | 0.047 | GABA uptake inhibitor | 0.037 0.032 DBMET01297 0.047 0.018 DBMET00238 0.045 0.02 DBMET01296 | DBMET00238 | |
| 0.121 | 0.112 | 0.156 | Hemostatic | 0.133 0.091 DBMET01297 0.143 0.077 DBMET00238 0.156 0.061 DBMET01296 | DBMET01296 | |
| 0.161 | 0.153 | 0.18 | ErbB-1 antagonist | 0.18 0.115 DBMET01298 0.18 0.115 DBMET01299 | DBMET01299 | |
| 0.081 | 0.074 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | 0.092 0.048 DBMET01297 0.105 0.028 DBMET00238 0.111 0.023 DBMET01298 0.111 0.023 DBMET01299 0.119 0.016 DBMET01296 | DBMET01296 | |
| 0.139 | 0.132 | 0.19 | Phospholipase C inhibitor | 0.137 0.134 DBMET01297 0.19 0.051 DBMET00238 0.189 0.052 DBMET01296 | DBMET00238 | |
| 0.079 | 0.073 | 0.081 | D-Ala-D-Ala ligase inhibitor | 0.079 0.071 DBMET01297 0.08 0.069 DBMET00238 0.081 0.067 DBMET01296 | DBMET01296 | |
| 0.052 | 0.047 | 0.062 | 5 Hydroxytryptamine 7 agonist | 0.062 0.028 DBMET00238 0.054 0.044 DBMET01298 0.054 0.044 DBMET01299 0.053 0.046 DBMET01296 | DBMET00238 | |
| 0.069 | 0.064 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | 0.069 0.063 DBMET01297 0.077 0.053 DBMET00238 0.078 0.053 DBMET01296 | DBMET01296 | |
| 0.058 | 0.053 | 0.058 | Heme oxygenase stimulant | 0.058 0.053 DBMET01297 | ||
| 0.037 | 0.033 | 0.037 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Oxytocin agonist | |||
| 0.187 | 0.183 | 0.241 | Transcription factor NF kappa B inhibitor | 0.199 0.17 DBMET01297 0.197 0.172 DBMET00237 0.193 0.176 DBMET00238 0.241 0.134 DBMET01298 0.241 0.134 DBMET01299 0.206 0.164 DBMET01296 | DBMET01299 | |
| 0.042 | 0.039 | 0.044 | Potassium channel Kv1.3 blocker | 0.044 0.036 DBMET01298 0.044 0.036 DBMET01299 | DBMET01299 | |
| 0.018 | 0.015 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.097 | 0.094 | 0.108 | TRPA1 agonist | 0.108 0.075 DBMET00238 | DBMET00238 | |
| 0.035 | 0.033 | 0.038 | Retinoid X receptor antagonist | 0.038 0.027 DBMET01297 | DBMET01297 | |
| 0.06 | 0.06 | 0.077 | Protein kinase C alpha inhibitor | 0.061 0.059 DBMET00237 0.077 0.036 DBMET00238 0.074 0.039 DBMET01296 | DBMET00238 | |
| 0.157 | 0.157 | 0.232 | Antioxidant | 0.199 0.114 DBMET01297 0.181 0.131 DBMET00237 0.163 0.15 DBMET00238 0.232 0.094 DBMET01298 0.232 0.094 DBMET01299 0.209 0.108 DBMET01296 | DBMET01299 | |
| 0.061 | 0.062 | 0.064 | 5 Hydroxytryptamine 1 antagonist | 0.064 0.059 DBMET01298 0.064 0.059 DBMET01299 | DBMET01299 | |
| 0.047 | 0.049 | 0.083 | Alcohol oxidase inhibitor | 0.083 0.023 DBMET00238 0.064 0.032 DBMET01296 | DBMET00238 | |
| 0.197 | 0.199 | 0.205 | Ca(v)3.3 blocker | 0.205 0.182 DBMET01298 0.205 0.182 DBMET01299 | DBMET01299 | |
| 0.045 | 0.047 | 0.048 | Squalene epoxidase inhibitor | 0.048 0.038 DBMET01297 | DBMET01297 | |
| 0.024 | 0.026 | 0.027 | Estrogen receptor beta agonist | 0.027 0.025 DBMET00237 | DBMET00237 | |
| 0.052 | 0.055 | 0.069 | Dopamine D2 antagonist | 0.059 0.05 DBMET01297 0.055 0.053 DBMET00240 0.069 0.044 DBMET01298 0.069 0.044 DBMET01299 | DBMET01299 | |
| 0.168 | 0.171 | 0.193 | DNA synthesis inhibitor | 0.193 0.134 DBMET00237 0.178 0.156 DBMET00238 0.173 0.164 DBMET01296 | DBMET00237 | |
| 0.03 | 0.035 | 0.032 | Retinoid X alpha receptor antagonist | 0.032 0.027 DBMET01297 | DBMET01297 | |
| 0.084 | 0.09 | 0.131 | Ferrochelatase inhibitor | 0.094 0.077 DBMET01297 0.131 0.047 DBMET00237 0.092 0.081 DBMET00238 0.103 0.068 DBMET01296 | DBMET00237 | |
| 0.072 | 0.078 | 0.082 | Antineoplastic alkaloid | 0.076 0.071 DBMET01297 0.082 0.063 DBMET01298 0.082 0.063 DBMET01299 | DBMET01299 | |
| 0.019 | 0.025 | 0.027 | Dopamine D1 agonist | 0.027 0.011 DBMET01297 0.023 0.016 DBMET01298 0.023 0.016 DBMET01299 0.025 0.013 DBMET01296 | DBMET01297 | |
| 0.087 | 0.095 | 0.095 | Toll-Like receptor 4 antagonist | 0.093 0.083 DBMET00237 0.095 0.078 DBMET00238 0.095 0.079 DBMET01298 0.095 0.079 DBMET01299 0.091 0.086 DBMET01296 | DBMET01299 | |
| 0.014 | 0.023 | 0.021 | Melanocortin 1 agonist | 0.021 0.019 DBMET00238 | DBMET00238 | |
| 0.028 | 0.037 | 0.034 | 5-Alpha-reductase inhibitor | 0.034 0.029 DBMET00237 | DBMET00237 | |
| 0.129 | 0.139 | 0.218 | DNA methylase inhibitor | 0.152 0.116 DBMET01297 0.218 0.068 DBMET01298 0.218 0.068 DBMET01299 | DBMET01299 | |
| 0.056 | 0.07 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.025 DBMET00237 0.063 0.037 DBMET00238 0.063 0.037 DBMET01296 | DBMET00237 | |
| 0.036 | 0.051 | 0.069 | NMDA 2A receptor antagonist | 0.058 0.031 DBMET00237 0.069 0.025 DBMET00238 0.046 0.042 DBMET01296 | DBMET00238 | |
| 0.088 | 0.105 | 0.22 | MAO inhibitor | 0.22 0.035 DBMET00240 | DBMET00240 | |
| 0.073 | 0.09 | 0.147 | HIV-1 integrase (Overall Integration) inhibitor | 0.094 0.06 DBMET01297 0.116 0.042 DBMET00238 0.147 0.026 DBMET01296 | DBMET01296 | |
| 0.032 | 0.05 | 0.043 | NMDA receptor subunit 3B antagonist | 0.043 0.032 DBMET00238 | DBMET00238 | |
| 0.044 | 0.063 | 0.057 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET00237 0.052 0.044 DBMET00238 0.057 0.035 DBMET01296 | DBMET01296 | |
| 0.086 | 0.105 | 0.098 | Protein kinase C gamma inhibitor | 0.098 0.08 DBMET00237 | DBMET00237 | |
| 0.026 | 0.046 | 0.037 | Melanocortin 1 antagonist | 0.037 0.028 DBMET00238 0.033 0.031 DBMET01296 | DBMET00238 | |
| 0.041 | 0.062 | 0.048 | Protein kinase C eta inhibitor | 0.048 0.046 DBMET00237 | DBMET00237 | |
| 0.132 | 0.154 | 0.19 | Death-associated protein kinase 2 inhibitor | 0.147 0.114 DBMET01297 0.176 0.059 DBMET00238 0.19 0.043 DBMET01296 | DBMET01296 | |
| 0.066 | 0.087 | 0.095 | Alpha 2 adrenoreceptor antagonist | 0.076 0.071 DBMET01297 0.084 0.062 DBMET00237 0.095 0.052 DBMET01298 0.095 0.052 DBMET01299 | DBMET01299 | |
| 0.055 | 0.077 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.075 0.055 DBMET00237 0.083 0.048 DBMET00238 0.088 0.043 DBMET01296 | DBMET01296 | |
| 0.134 | 0.156 | 0.172 | Insulin sensitizer | 0.172 0.104 DBMET00237 0.144 0.142 DBMET01296 | DBMET00237 | |
| 0.051 | 0.073 | 0.126 | 5 Hydroxytryptamine 1F antagonist | 0.126 0.022 DBMET00237 | DBMET00237 | |
| 0.042 | 0.066 | 0.053 | Leukotriene B4 antagonist | 0.053 0.038 DBMET00237 | DBMET00237 | |
| 0.024 | 0.049 | 0.037 | NMDA receptor subunit 3A antagonist | 0.037 0.028 DBMET00238 | DBMET00238 | |
| 0.143 | 0.168 | 0.186 | Vasodilator | 0.164 0.138 DBMET01297 0.156 0.149 DBMET00238 0.186 0.116 DBMET01298 0.186 0.116 DBMET01299 0.18 0.121 DBMET01296 | DBMET01299 | |
| 0.053 | 0.078 | 0.116 | Phosphodiesterase 4D inhibitor | 0.116 0.03 DBMET01298 0.116 0.03 DBMET01299 | DBMET01299 | |
| 0.144 | 0.172 | 0.246 | Interleukin agonist | 0.178 0.141 DBMET01297 0.227 0.097 DBMET00237 0.22 0.103 DBMET00238 0.246 0.082 DBMET01296 | DBMET01296 | |
| 0.087 | 0.116 | 0.129 | Electron transport complex I inhibitor | 0.129 0.036 DBMET00237 0.129 0.037 DBMET01298 0.129 0.037 DBMET01299 | DBMET01299 | |
| 0.065 | 0.095 | 0.086 | Neuropeptide Y antagonist | 0.086 0.05 DBMET00238 | DBMET00238 | |
| 0.094 | 0.124 | 0.121 | NADPH oxidase inhibitor | 0.121 0.082 DBMET01298 0.121 0.082 DBMET01299 | DBMET01299 | |
| 0.064 | 0.095 | 0.072 | Viral attachment inhibitor | 0.072 0.071 DBMET01296 | DBMET01296 | |
| 0.021 | 0.054 | 0.036 | Catechol O-methyltransferase inhibitor | 0.036 0.018 DBMET01297 0.033 0.022 DBMET01296 | DBMET01297 | |
| 0.071 | 0.105 | 0.095 | Vanilloid agonist | 0.084 0.06 DBMET01297 0.095 0.039 DBMET01298 0.095 0.039 DBMET01299 0.083 0.061 DBMET01296 | DBMET01299 | |
| 0.052 | 0.086 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.027 DBMET00237 0.073 0.03 DBMET00238 0.074 0.029 DBMET01296 | DBMET00237 | |
| 0.077 | 0.112 | 0.106 | Adenylate cyclase inhibitor | 0.095 0.089 DBMET01297 0.106 0.079 DBMET00237 0.103 0.082 DBMET01296 | DBMET00237 | |
| 0.068 | 0.105 | 0.116 | Breast cancer-resistant protein inhibitor | 0.116 0.042 DBMET01298 0.116 0.042 DBMET01299 | DBMET01299 | |
| 0.087 | 0.124 | 0.138 | Alpha-N-acetylglucosaminidase inhibitor | 0.121 0.076 DBMET00238 0.138 0.063 DBMET01296 | DBMET01296 | |
| 0.066 | 0.104 | 0.356 | Bronchodilator | 0.175 0.023 DBMET00237 0.356 0.007 DBMET00240 0.115 0.048 DBMET01298 0.115 0.048 DBMET01299 | DBMET00240 | |
| 0.093 | 0.132 | 0.119 | Interleukin 4 antagonist | 0.117 0.09 DBMET00237 0.11 0.102 DBMET00238 0.109 0.102 DBMET01298 0.109 0.102 DBMET01299 0.119 0.086 DBMET01296 | DBMET01296 | |
| 0.037 | 0.077 | 0.047 | Nicotinic receptor alpha4 subunit antagonist | 0.047 0.038 DBMET00238 0.047 0.039 DBMET01296 | DBMET01296 | |
| 0.072 | 0.112 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | 0.109 0.043 DBMET00237 0.093 0.066 DBMET00238 | DBMET00237 | |
| 0.03 | 0.072 | 0.045 | Carbonic anhydrase XIV inhibitor | 0.043 0.042 DBMET00238 0.045 0.039 DBMET01296 | DBMET01296 | |
| 0.039 | 0.084 | 0.057 | Dopamine agonist | 0.057 0.055 DBMET01297 | DBMET01297 | |
| 0.013 | 0.059 | 0.04 | Arginase inhibitor | 0.034 0.028 DBMET00238 0.04 0.022 DBMET01296 | DBMET01296 | |
| 0.069 | 0.116 | 0.107 | Expectorant | 0.09 0.082 DBMET00237 0.107 0.062 DBMET01298 0.107 0.062 DBMET01299 | DBMET01299 | |
| 0.069 | 0.118 | 0.253 | GABA C receptor agonist | 0.221 0.017 DBMET00238 0.253 0.013 DBMET01296 | DBMET01296 | |
| 0.035 | 0.088 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.046 DBMET00237 | DBMET00237 | |
| 0.018 | 0.071 | 0.105 | Kinesin antagonist | 0.105 0.007 DBMET00240 | DBMET00240 | |
| 0.018 | 0.071 | 0.105 | Kinesin-like protein 1 inhibitor | 0.105 0.007 DBMET00240 | DBMET00240 | |
| 0.041 | 0.095 | 0.072 | Sphingosine kinase inhibitor | 0.066 0.03 DBMET00238 0.072 0.022 DBMET01296 | DBMET01296 | |
| 0.055 | 0.11 | 0.078 | Keratolytic | 0.078 0.051 DBMET00238 0.078 0.051 DBMET01296 | DBMET01296 | |
| 0.112 | 0.169 | 0.149 | Hepatoprotectant | 0.149 0.11 DBMET01298 0.149 0.11 DBMET01299 | DBMET01299 | |
| 0.129 | 0.188 | 0.373 | Tumour necrosis factor alpha release inhibitor | 0.166 0.138 DBMET01297 0.373 0.032 DBMET00240 0.263 0.069 DBMET01298 0.263 0.069 DBMET01299 0.184 0.123 DBMET01296 | DBMET00240 | |
| 0.073 | 0.132 | 0.102 | Mucolytic | 0.102 0.075 DBMET01298 0.102 0.075 DBMET01299 | DBMET01299 | |
| 0.036 | 0.097 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | 0.054 0.047 DBMET00238 | DBMET00238 | |
| 0.103 | 0.167 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.111 DBMET00238 | DBMET00238 | |
| 0.042 | 0.106 | 0.07 | Porphobilinogen synthase inhibitor | 0.064 0.062 DBMET00238 0.07 0.056 DBMET01296 | DBMET01296 | |
| 0.049 | 0.114 | 0.079 | Ornithine decarboxylase inhibitor | 0.079 0.069 DBMET01296 | DBMET01296 | |
| 0.24 | 0.305 | 0.276 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.276 0.247 DBMET00238 0.272 0.252 DBMET01296 | DBMET00238 | |
| 0.034 | 0.099 | 0.05 | Glucose-6-phosphate translocase inhibitor | 0.05 0.038 DBMET01298 0.05 0.038 DBMET01299 | DBMET01299 | |
| 0.096 | 0.164 | 0.203 | Amyloid beta aggregation inhibitor | 0.14 0.116 DBMET01297 0.203 0.076 DBMET01298 0.203 0.076 DBMET01299 | DBMET01299 | |
| 0.057 | 0.128 | 0.099 | GABA B receptor agonist | 0.096 0.02 DBMET00238 0.099 0.017 DBMET01296 | DBMET01296 | |
| 0.062 | 0.134 | 0.093 | UDP-glucose 4-epimerase inhibitor | 0.087 0.077 DBMET00238 0.093 0.069 DBMET01296 | DBMET01296 | |
| 0.039 | 0.112 | 0.079 | Beta adrenoreceptor antagonist | 0.076 0.03 DBMET00238 0.079 0.028 DBMET01296 | DBMET01296 | |
| 0.048 | 0.121 | 0.091 | Somatostatin 1 agonist | 0.091 0.041 DBMET00237 0.07 0.065 DBMET00238 | DBMET00237 | |
| 0.036 | 0.11 | 0.056 | Vanilloid 2 antagonist | 0.056 0.029 DBMET01298 0.056 0.029 DBMET01299 0.05 0.041 DBMET01296 | DBMET01299 | |
| 0.142 | 0.218 | 0.236 | Peptidyltransferase inhibitor | 0.236 0.061 DBMET00237 | DBMET00237 | |
| 0.024 | 0.1 | 0.046 | Sphingosine kinase 1 inhibitor | 0.04 0.032 DBMET00238 0.046 0.021 DBMET01296 | DBMET01296 | |
| 0.036 | 0.116 | 0.068 | Phenylalanine 4-hydroxylase inhibitor | 0.068 0.049 DBMET00237 0.06 0.058 DBMET00238 0.067 0.049 DBMET01296 | DBMET00237 | |
| 0.073 | 0.162 | 0.114 | Cyclooxygenase 3 inhibitor | 0.114 0.085 DBMET00238 0.112 0.087 DBMET01296 | DBMET00238 | |
| 0.153 | 0.246 | 0.211 | Insulysin inhibitor | 0.211 0.141 DBMET00238 0.209 0.143 DBMET01296 | DBMET00238 | |
| 0.045 | 0.14 | 0.096 | Adrenaline agonist | 0.096 0.04 DBMET00237 | DBMET00237 | |
| 0.151 | 0.25 | 0.201 | Antithrombotic | 0.201 0.176 DBMET00237 0.195 0.184 DBMET01296 | DBMET00237 | |
| 0.027 | 0.127 | 0.064 | 5 Hydroxytryptamine 2A agonist | 0.064 0.043 DBMET00238 | DBMET00238 | |
| 0.041 | 0.147 | 0.121 | MAO A inhibitor | 0.121 0.052 DBMET00240 | DBMET00240 | |
| 0.014 | 0.122 | 0.062 | Vitamin D receptor antagonist | 0.062 0.004 DBMET00237 | DBMET00237 | |
| 0.018 | 0.135 | 0.046 | Phosphodiesterase 4A inhibitor | 0.046 0.038 DBMET01298 0.046 0.038 DBMET01299 | DBMET01299 | |
| 0.16 | 0.285 | 0.264 | Calcium channel activator | 0.216 0.19 DBMET00237 0.264 0.13 DBMET00238 0.237 0.163 DBMET01296 | DBMET00238 | |
| 0.135 | 0.266 | 0.199 | Nitric-oxide synthase stimulant | 0.187 0.114 DBMET00238 0.199 0.091 DBMET01296 | DBMET01296 | |
| 0.056 | 0.187 | 0.121 | Amylase inhibitor | 0.116 0.084 DBMET00238 0.121 0.08 DBMET01296 | DBMET01296 | |
| 0.045 | 0.183 | 0.071 | Sphingosine 1-phosphate receptor antagonist | 0.071 0.067 DBMET00237 | DBMET00237 | |
| 0.013 | 0.155 | 0.067 | Beta tubulin antagonist | 0.067 0.036 DBMET01298 0.067 0.036 DBMET01299 | DBMET01299 | |
| 0.021 | 0.166 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.047 0.041 DBMET00238 0.048 0.039 DBMET01296 | DBMET01296 | |
| 0.02 | 0.174 | 0.049 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 DBMET01296 | DBMET01296 | |
| 0.019 | 0.177 | 0.051 | Phenylethanolamine N methyltransferase inhibitor | 0.051 0.014 DBMET00238 0.051 0.014 DBMET01296 | DBMET01296 | |
| 0.089 | 0.248 | 0.127 | CF transmembrane conductance regulator agonist | 0.127 0.126 DBMET00238 | DBMET00238 | |
| 0.098 | 0.257 | 0.138 | MAP kinase kinase 4 inhibitor | 0.138 0.09 DBMET00238 | DBMET00238 | |
| 0.017 | 0.19 | 0.049 | Neuraminidase (Influenza A) inhibitor | 0.049 0.026 DBMET00237 | DBMET00237 | |
| 0.034 | 0.207 | 0.102 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.089 DBMET01296 | DBMET01296 | |
| 0.158 | 0.342 | 0.277 | Apoptosis agonist | 0.277 0.19 DBMET01298 0.277 0.19 DBMET01299 | DBMET01299 | |
| 0.135 | 0.321 | 0.218 | Caspase 3 stimulant | 0.218 0.145 DBMET01298 0.218 0.145 DBMET01299 | DBMET01299 | |
| 0.051 | 0.238 | 0.096 | Nav1.4 sodium channel blocker | 0.096 0.081 DBMET00237 | DBMET00237 | |
| 0.024 | 0.217 | 0.145 | Phosphodiesterase IV inhibitor | 0.145 0.024 DBMET00240 | DBMET00240 | |
| 0.048 | 0.243 | 0.226 | Bone formation stimulant | 0.226 0.03 DBMET00237 | DBMET00237 | |
| 0.02 | 0.217 | 0.063 | Myc inhibitor | 0.062 0.027 DBMET00238 0.063 0.026 DBMET01296 | DBMET01296 | |
| 0.007 | 0.209 | 0.03 | Prostaglandin D2 agonist | 0.03 0.023 DBMET00237 | DBMET00237 | |
| 0.013 | 0.241 | 0.06 | Neuraminidase inhibitor | 0.06 0.044 DBMET00237 | DBMET00237 | |
| 0.018 | 0.259 | 0.062 | Phosphodiesterase III inhibitor | 0.062 0.05 DBMET00240 | DBMET00240 | |
| 0.146 | 0.392 | 0.194 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.194 0.183 DBMET00238 | DBMET00238 | |
| 0.018 | 0.272 | 0.065 | Neuraminidase (influenza) inhibitor | 0.065 0.042 DBMET00237 | DBMET00237 | |
| 0.035 | 0.308 | 0.148 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.148 0.062 DBMET00240 | DBMET00240 | |
| 0.076 | 0.374 | 0.272 | Hypoglycemic | 0.272 0.064 DBMET00237 | DBMET00237 | |
| 0.025 | 0.351 | 0.138 | Tubulin antagonist | 0.138 0.065 DBMET01298 0.138 0.065 DBMET01299 | DBMET01299 | |
| 0.005 | 0.333 | 0.05 | 5 Hydroxytryptamine 2C agonist | 0.05 0.027 DBMET00238 0.049 0.029 DBMET01296 | DBMET00238 | |
| 0.011 | 0.375 | 0.05 | Mineralocorticoid receptor antagonist | 0.05 0.031 DBMET00240 | DBMET00240 | |
| 0.041 | 0.481 | 0.185 | Polo-like kinase-3 inhibitor | 0.185 0.054 DBMET00240 | DBMET00240 | |
| 0.058 | 0.527 | 0.37 | Toll-Like receptor agonist | 0.37 0.073 DBMET00237 | DBMET00237 | |
| 0.058 | 0.528 | 0.355 | Toll-Like receptor 7 agonist | 0.355 0.079 DBMET00237 | DBMET00237 | |
| 0.028 | 0.501 | 0.139 | Antimitotic | 0.139 0.134 DBMET01298 0.139 0.134 DBMET01299 | DBMET01299 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |